Search results for " radiotherapy"

showing 10 items of 156 documents

Use of bone scintigraphy in the early diagnosis of bisphosphonate related osteonecrosis of the jaw. Case report and review of the literature

2018

The main aim of the present report is to show the potential utility of bone scintigraphy for the diagnosis of jaw osteonecrosis. We report the history of a 62-year-old woman underwent breast cancer surgery in 2010. Moreover, patient received postoperative radiotherapy and chemotherapy. Intravenous bisphosphonates were also added to the treatment strategy to reduce the risk of bone metastasis. However, a hypermetabolic focus on left hemimandible was evidenced with a bone scintigraphy during follow up. After a careful study, the diagnosis of Bisphosphonate Related Ostneonecrosis of the Jaw (BRONJ) was carried out. This case highlights that bone scintigraphy may be extremely helpful for the ea…

Chemotherapymedicine.medical_specialtyOral Medicine and Pathologymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentPostoperative radiotherapyEarly detectionBone metastasisCase Report030206 dentistryBisphosphonate:CIENCIAS MÉDICAS [UNESCO]medicine.disease03 medical and health sciences0302 clinical medicineBreast cancerBone scintigraphy030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASmedicineRadiologybusinessOsteonecrosis of the jawGeneral Dentistry
researchProduct

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

2004

Background: The benefit of neoadjuvant chemoradiotherapy in oesophageal cancer has been extensively studied but data on survival are still equivocal. Objective: To assess the effectiveness of chemoradiotherapy followed by surgery in the reduction of mortality in patients with resectable oesophageal cancer. Methods: Computerised bibliographic searches of MEDLINE and CANCERLIT (1970–2002) were supplemented with hand searches of reference lists. Study selection: Studies were included if they were randomised controlled trials (RCTs) comparing preoperative chemoradiotherapy plus surgery with surgery alone, and if they included patients with resectable histologically proven oesophageal cancer wit…

medicine.medical_specialtyEsophageal Neoplasmsmedicine.medical_treatmentlaw.inventionPostoperative ComplicationsRandomized controlled triallawChemotherapyHumansMedicineEsophageal NeoplasmAdjuvantRandomized Controlled Trials as TopicIntention-to-treat analysisRadiotherapybusiness.industryMortality rateGastroenterologyCancerOdds ratiomedicine.diseaseChemotherapy Adjuvant; Esophageal Neoplasms; Esophagectomy; Humans; Postoperative Complications; Radiotherapy Adjuvant; Randomized Controlled Trials; Survival Analysis; Treatment OutcomeSurvival AnalysisSurgeryEsophagectomyRadiation therapyOesophagusTreatment OutcomeChemotherapy AdjuvantEsophagectomyRandomized Controlled TrialChemotherapy; Adjuvant; Esophageal Neoplasms; Esophagectomy; Humans; Postoperative Complications; Radiotherapy; Randomized Controlled Trials as Topic; Survival Analysis; Treatment OutcomeRadiotherapy AdjuvantPostoperative ComplicationSurvival AnalysibusinessChemoradiotherapyHumanGut
researchProduct

Preliminary magnetic resonance relaxometric analysis of Fricke gel dosimeters produced with polyvinyl alcohol and glutaraldehyde

2017

This work describes the preliminary analysis of Fricke gels dosimeters characterized by a new formulation making use of a matrix of polyvinyl alcohol cross-linked by adding glutaraldehyde and analyzed by means of nuclear magnetic resonance relaxometry. In previous optical studies, these gels have shown promising dosimetric features in terms of photon sensitivity and low diffusion of ferric ions produced after irradiation. In this work, we used a portable nuclear magnetic resonance relaxometer to measure the relaxation times (which are important for dosimetric applications) of these gel materials. For this purpose, we performed a study for optimizing the acquisition parameters with a nuclear…

gelMaterials science02 engineering and technology01 natural sciencesPolyvinyl alcoholchemistry.chemical_compound0103 physical sciencesmedicinelcsh:Nuclear and particle physics. Atomic energy. RadioactivityFricke gelSafety Risk Reliability and QualityradiotherapySettore CHIM/02 - Chimica FisicaDosimetermedicine.diagnostic_testdosimetry010308 nuclear & particles physicsSettore FIS/01 - Fisica SperimentaleMagnetic resonance imaging021001 nanoscience & nanotechnologySettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Dosimetry Gel NMR PVA GTA radiotherapynuclear magnetic resonancepolyvinyl alcoholNuclear Energy and Engineeringchemistryglutaraldehydelcsh:QC770-798Glutaraldehyde0210 nano-technologySettore MED/36 - Diagnostica Per Immagini E RadioterapiaDosimetry; Gel; Glutaraldehyde; Nuclear magnetic resonance; Polyvinyl alcohol; RadiotherapyNuclear chemistryNuclear Technology and Radiation Protection
researchProduct

Palliative splenic irradiation in primary and post PV/ET myelofibrosis: outcomes and toxicity of three radiation schedules

2009

Splenectomy and splenic irradiation (SI) are the sole treatment modalities to control drug resistant splenomegaly in patients with myelofibrosis (MF). SI has been used in poor surgical candidates but optimal total dose and fractionation are unclear. We retrospectively reviewed 14 MF patients with symptomatic splenomegaly. Patients received a median of 10 fractions in two weeks. Fraction size ranged from 0.2–1.4 Gy, and total dose varied from 2–10.8 Gy per RT course. Overall results indicate that 81.8% of radiation courses achieved a significant spleen reduction. Splenic pain relief and gastrointestinal symptoms reduction were obtained in 94% and 91% of courses, respectively. Severe cytopeni…

medicine.medical_specialtypalliationmedicine.medical_treatmentSplenectomyMyelofibrosisSpleenSubgroup analysisGastroenterologyArticleInternal medicineMedicinemyelofibrosis; splenomegaly; palliation; radiotherapy; low-dose irradiationMyelofibrosisAdverse effectradiotherapylow dose irradiationsplenomegalylcsh:RC633-647.5business.industrylow-dose irradiation.lcsh:Diseases of the blood and blood-forming organsHematologymedicine.diseaseSurgeryRadiation therapymedicine.anatomical_structureTolerabilityToxicitybusinessHematology Reports
researchProduct

Optimal local control and tolerability of three-dimensional conformal radiation therapy in prostate cancer: A single institutional experience of dose…

2013

Aims To evaluate long-term late side effects, clinical and biochemical relapse in non-metastatic prostate cancer patients treated with dose escalation, from 74 to 78 Gy, by means of three dimensional conformal radiation therapy. Materials and Methods Clinical data of 125 patients with prostate cancer who underwent three-dimensional conformal radiation therapy were retrospectively evaluated. All patients were stratified, according to the NCCN classification, in low, intermediate and high risk, and all of them showed histologically proven adenocarcinoma stage T1–T3 with at least 2 years of follow-up. Late toxicity was analyzed using a modified Radiation Therapy Oncology Group toxicity scale. …

MaleCancer ResearchThree dimensional conformal radiation therapyUrinary BladderUrogenital SystemKaplan-Meier EstimateAdenocarcinomaDisease-Free SurvivalBiomarkers Tumor80 and overHumansLate toxicity; Local control; Prostate cancer; Radiation therapy; Three dimensional conformal radiation therapy; Adenocarcinoma; Aged; Aged 80 and over; Biomarkers Tumor; Disease-Free Survival; Gastrointestinal Tract; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Conformal; Rectum; Retrospective Studies; Urinary Bladder; Urogenital System; Medicine (all); Oncology; Cancer ResearchRadiation InjuriesAgedNeoplasm StagingRetrospective StudiesAged 80 and overProstate cancerTumorRadiotherapyConformalMedicine (all)RectumProstatic NeoplasmsRadiotherapy DosageGeneral MedicineMiddle AgedProstate-Specific AntigenRadiation therapyGastrointestinal TractItalyOncologyLocal controlRadiotherapy ConformalLate toxicityBiomarkers
researchProduct

Spinal metastases: Is stereotactic body radiation therapy supported by evidences?

2016

Stereotactic body radiotherapy (SBRT) is becoming widely adopted in the treatment of primary and secondary tumors. Spinal bone metastases are frequently discovered in cancer patients, and in the past have been usually treated with a palliative goal. Nevertheless, in some particular clinical settings, such as oligometastatic patients and/or those with a long life expectancy, spinal SBRT could be considered a valid therapeutic option to obtain long-lasting palliation and, when possible, with a curative goal. This review aims to summarize available clinical and dosimetric data of published studies about spinal SBRT.

medicine.medical_specialtyPalliative careStereotactic body radiation therapymedicine.medical_treatment2720 HematologyBone Neoplasms610 Medicine & healthClinical settingsRadiosurgeryRadiosurgery030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineDosimetryFractures CompressionPalliative radiotherapymedicineHumansSBRTSpinal NeoplasmsToxicitySpine metastasesbusiness.industryPalliative CareCompressionCancerRadiotherapy DosageHematologymedicine.disease10044 Clinic for Radiation OncologySurgeryTreatment OutcomeOncologyLocal controlDosimetry; Local control; Palliative radiotherapy; SBRT; Spine metastases; Toxicity; Bone Neoplasms; Evidence-Based Practice; Fractures Compression; Humans; Palliative Care; Radiotherapy Dosage; Spinal Fractures; Spinal Neoplasms; Treatment Outcome; Radiosurgery; Hematology; Oncology; Geriatrics and GerontologyEvidence-Based Practice030220 oncology & carcinogenesisSpinal Fractures2730 OncologySecondary tumorsGeriatrics and GerontologySpinal metastasesbusinessFracturesStereotactic body radiotherapyCritical Reviews in Oncology/Hematology
researchProduct

The impact of head and neck radiotherapy on the dentine-enamel junction: a systematic review

2019

Background Radiotherapy is widely used in contemporary head and neck cancer treatment protocols. The ability of head and neck radiotherapy (HNRT) to cause direct radiogenic destruction to the teeth is one of the most controversial topics in the field of oral oncology. Therefore, this systematic review aimed to investigate ionising radiation as an independent factor for physical and chemical changes on the dentine-enamel junction (DEJ), a pivotal dental topography for the onset and progression of radiation-related caries (RRC) and enamel delamination. Material and Methods Systematic searches were conducted on three databases: Scopus, MEDLINE (Via PubMed) and Embase (Elsevier). Laboratory stu…

medicine.medical_treatmentDentistryReviewDental Caries03 medical and health sciences0302 clinical medicinestomatognathic systemHead and neck radiotherapyDentinHumansMedicineDental EnamelMethodological qualityGeneral DentistryOral Medicine and PathologyEnamel paintbusiness.industryHead and neck cancerCancer030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseQuality of evidenceRadiation therapystomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngologyHead and Neck Neoplasmsvisual_artDentinUNESCO::CIENCIAS MÉDICASvisual_art.visual_art_mediumSurgerybusinessToothMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

9 Development of an experimental tool to evaluate normal tissue 3D doses in external-beam radiotherapy

2018

Introduction Recently, cancer treatment improvement enabled an increase in patients’ survival rate. In more than half of the cases, radiotherapy participates in the cure for cancer. The efficacy of this technique is well known but it inevitably delivers doses to normal tissues exposing them to radio-induced complications risks [1] . Moreover, the longer patients’ life expectancy increases the risk of developing long-term complications such as second cancers. Thus, evaluating the risks following cancer treatment involving radiotherapy constitutes a major challenge. In this context, an experimental tool has been developed to evaluate normal tissue doses delivered by the different radiotherapy…

Contouringbusiness.industrymedicine.medical_treatmentBiophysicsGeneral Physics and AstronomyDose profileContext (language use)General MedicineGel dosimetryImaging phantom030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinePlanned Dose030220 oncology & carcinogenesismedicineRadiology Nuclear Medicine and imagingExternal beam radiotherapyNuclear medicinebusinessRadiation treatment planningPhysica Medica
researchProduct

Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment.

2016

The present study investigated the combination of levonorgestrel-releasing intrauterine device (LNG-IUD) insertion and palliative radiotherapy (RT) as a potential approach for treating frail, elderly endometrial cancer (EC) patients considered unfit for curative oncological treatments. The inclusion criteria were an age of ≥65 years, pathological confirmation of a uterine neoplasm, a Charlson comorbidity index (CCI) value of ≥4 and the presence of vaginal bleeding. Patients underwent intrauterine insertion of an LNG-IUD, and thereafter, received a total dose of 30 Gy at 3 Gy per fraction, over 10 days. The clinical target volume (CTV) was defined as the uterus and disease-involved tissues i…

Cancer Researchmedicine.medical_specialtymedicine.drug_classUterusIntrauterine deviceelderlyuterine cancer03 medical and health sciences0302 clinical medicineUterine cancermedicineVaginal bleedingUterine NeoplasmSettore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIAprogestin-releasing intrauterine device030219 obstetrics & reproductive medicinebusiness.industryEndometrial cancerCancerArticlesmedicine.diseaseSurgeryElderly; Palliative radiotherapy; Progestin-releasing intrauterine device; Uterine cancer; Oncology; Cancer Researchmedicine.anatomical_structureOncology030220 oncology & carcinogenesispalliative radiotherapymedicine.symptombusinessProgestinOncology letters
researchProduct

Stereotaktisten annossuunnitelmien verifiointi Compass-järjestelmällä

2016

sädehoitostereotaktinen sädehoitoalgoritmitlaskentamallitVMATstereotactic radiotherapyalgorithmsradiotherapy
researchProduct